{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:47:27Z","timestamp":1759009647594},"reference-count":24,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.5144\/0256-4947.2005.409","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T21:48:18Z","timestamp":1533592098000},"page":"409-412","source":"Crossref","is-referenced-by-count":7,"title":["In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against\n            <i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.5144","volume":"25","author":[{"given":"Sinem","family":"Akcali","sequence":"first","affiliation":[{"name":"Celal Bayar University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suheyla","family":"Surucuoglu","sequence":"additional","affiliation":[{"name":"Celal Bayar University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"Cicek","sequence":"additional","affiliation":[{"name":"Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beril","family":"Ozbakkaloglu","sequence":"additional","affiliation":[{"name":"Celal Bayar University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"issue":"1","key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.33.1.1","article-title":"Mycobacteria and the new quinolones","volume":"33","author":"Leysen DC","year":"1989","journal-title":"Antimic Agents Chemother"},{"issue":"6","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/32.6.797","article-title":"In vitro activities of quinolones against mycobacteria","volume":"32","author":"Garcia-Rodriguez JA","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/AAC.36.11.2544","article-title":"Activities of various quinolone antibiotics against Mycobacterium leprae infected mice","volume":"36","author":"Gelber RH","year":"1992","journal-title":"Antimic Agents Chemother"},{"issue":"5","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/516116","article-title":"The clinical use of fluoroquinolones for the treatment of mycobacterial diseases","volume":"25","author":"Alangaden GJ","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.28.5.716","article-title":"The fluoroquinolones: pharmacology, clinical uses, and toxicities","volume":"28","author":"Hooper DC","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jac\/47.4.447","article-title":"Inhibitory activitiy of quinolones against DNA gyrase of Mycobacterium tuberculosis","volume":"47","author":"Onodera Y","year":"2001","journal-title":"J Antimic Chemother"},{"key":"e_1_3_1_8_2","volume-title":"Public Health Mycobacteriology, A Guide for the Level III Laboratory","author":"Kent PT","year":"1985"},{"key":"e_1_3_1_9_2","unstructured":"Guidelines for surveillance of drug resistance in tuberculosis. WHO\/TB\/2003.320-WHO\/CDS\/CSR\/RMD\/ 2003; 3 :9-11."},{"issue":"4","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000065815","article-title":"Primary antituberculosis drug resistance at Turkish Military Chest Diseases Hospital in Istanbul","volume":"11","author":"Kartaloglu Z","year":"2002","journal-title":"Medical Principles and Practise"},{"issue":"3","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.1995.03520270054031","article-title":"Global epidemiology of tuberculosis morbidity and mortality of a worldwide epidemic","volume":"273","author":"Raviglione MC","year":"1995","journal-title":"J Am Med Assoc"},{"issue":"6","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/infdis\/169.6.1189","article-title":"The neglected global tuberculosis problem: A report of the 1992 World Congress of Tuberculosis","volume":"169","author":"Snider DE","year":"1994","journal-title":"J Infect Dis"},{"issue":"7","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations","volume":"53","author":"Joint Tuberculosis Committee of the British Thoracic Surgary","year":"1998","journal-title":"Thorax"},{"key":"e_1_3_1_14_2","unstructured":"Guidelines for the managements of drug resistance tuberculosis. WHO\/TB\/96.210 (rev 1) 1997;1-47."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199500492-00004","article-title":"Quinolone mode of action","volume":"49","author":"Hooper DC","year":"1995","journal-title":"Drugs"},{"issue":"7","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1183\/09031936.95.08071184","article-title":"Drug resistant tuberculosis in the 1990s","volume":"8","author":"Yew WW","year":"1995","journal-title":"Eur Respir J"},{"key":"e_1_3_1_17_2","first-page":"714","article-title":"New drugs for tuberculosis","volume":"20","author":"Grassi C","year":"1995","journal-title":"Eur Respir J Suppl"},{"issue":"1","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s101560050043","article-title":"Prospects for development of new antimycobacterial drugs","volume":"6","author":"Tomioka H","year":"2000","journal-title":"J Infect Chemother"},{"issue":"3","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0924-8579(00)00337-X","article-title":"In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis","volume":"17","author":"Rodriguez JC","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_1_20_2","unstructured":"Abstract. 93rd General Meeting of American Society on Microbiology Abstract. 93rd General Meeting of American Society on Microbiology WM Gross DA Bonato FS Vadney S Campbell In vitro activity of ciprofloxacin in multiple drug resistant strains ofMycobacterium tuberculosis 1985\u20131992 1993 173"},{"issue":"7","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.37.7.1556","article-title":"Ciprofloxacin susceptibility testing by MIC and disc elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex","volume":"37","author":"LaBombardi VJ","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/44.5.647","article-title":"Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin","volume":"44","author":"Vacher S","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002849900095","article-title":"In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages","volume":"33","author":"Rastogi N","year":"1996","journal-title":"Current Microbiol"},{"issue":"6","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/40.6.885","article-title":"In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis","volume":"40","author":"Hoffner SE","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/26.3.381","article-title":"Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp","volume":"26","author":"Van Caekenberghe D","year":"1990","journal-title":"J Antimicrob Chemother"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/volume-25\/vol25iss5\/999.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T10:58:52Z","timestamp":1559473132000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2005.409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.5144\/0256-4947.2005.409"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2005.409","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}